Biden Administration Proposes Novel Use Of Price As Justification For Agency Exercise Of March-In Rights For Government-Funded Inventions | Morrison & Foerster LLP - Government Contracts Insights

Presented as part of its effort to lower what it views as excessive prices for prescription drugs, the Biden administration on December 7, 2023, announced the release of a proposed...

Related Keywords

California ,United States ,Lawrence Livermore National Laboratory ,Bernie Sanders ,Astellas Pharma ,America Ph ,Elizabeth Warren ,Us Chamber ,Ventana Medical Systems Inc ,University Of California ,Morrison Foerster ,Department Of Health ,Department Of Defense Do ,Pfizer ,Development In Support Of Domestic Manufacturing ,Prior Biden Administration Activity ,Interagency Working Group For Bayh Dole ,Drug Administration ,Us Department Of Energy Do ,Morrison Foerster Llp ,Order On Federal Research ,National Institutes Of Science ,Human Services ,National Institutes Of Health ,Bayh Dole Act ,National Institutes ,Draft Interagency Guidance Framework ,March In Rights ,Draft Framework ,Exercise March In ,Pharmaceutical Research ,Biden Administration Activity Related ,Executive Order ,President Biden ,Federal Research ,Domestic Manufacturing ,United States Jobs ,Interagency Working Group ,Organized Comments ,Dole Act ,Ventana Medical Systems ,Roche Diagnostics ,